A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease

References

• Kahn MR, Robbins MJ, Kim MC, et al. Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol. 2013;10:261–273.23419899
   PubMed Web of Science ®Google Scholar
• Gajjala PR, Fliser D, Speer T, et al. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Nephrol Dial Transplant. 2015;30:1814–1824.25862763
   PubMed Web of Science ®Google Scholar
• Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–19.27102194
   PubMed Web of Science ®Google Scholar
• Rhee CM, Kovesdy CP. Epidemiology: spotlight on CKD deaths—increasing mortality worldwide. Nat Rev Nephrol. 2015;11:199–200.25734769
   PubMed Web of Science ®Google Scholar
• Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation. 2016;133:518–536.26831434
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–725.31301983
   PubMed Web of Science ®Google Scholar
• Shoji T, Abe T, Matsuo H, et al. Chronic kidney disease, dyslipidemia, and atherosclerosis. J Atheroscler Thromb. 2012;19(4):299–315.22166970
   PubMed Web of Science ®Google Scholar
• Valdivielso JM, Rodríguez-Puyol D, Pascual J, et al. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol. 2019;39(10):1938–1966.31412740
   PubMed Web of Science ®Google Scholar
• Zalba G, Fortuño A, Díez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant. 2006;21(10):2686–2690.16861737
   PubMed Web of Science ®Google Scholar
• Swaminathan S, Shah SV. Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int. 2011;80(5):453–463.21697810
   PubMed Web of Science ®Google Scholar
• Drüeke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol. 2010;6:723–735.20978469
   PubMed Web of Science ®Google Scholar
• Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562.21107446
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A. Kidney disease: improving global outcomes chronic kidney disease guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830.23732715
   PubMed Web of Science ®Google Scholar
• Zaid M, Fujiyoshi A, Kadota A, et al. Coronary artery calcium and carotid artery intima media thickness and plaque: clinical use in need of clarification. J Atheroscler Thromb. 2017;24:227–239.27904029
   PubMed Web of Science ®Google Scholar
• Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111.18261694
   PubMed Web of Science ®Google Scholar
• Bro S, Bentzon JF, Falk E, et al. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol. 2003;14:2466–2474.14514724
   PubMed Web of Science ®Google Scholar
• Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1599–1605.18815240
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Zhong J, Yancey PG, et al. Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype. Atherosclerosis. 2015;242(1):56–64.26184694
   PubMed Web of Science ®Google Scholar
• Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13:368–380.28392564
   PubMed Web of Science ®Google Scholar
• Hsu S, Rifkin DE, Criqui MH, et al. Relationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease. J Vasc Surg. 2018;67(6):1855–1863.e1.29276107
   PubMed Web of Science ®Google Scholar
• Palanca A, Castelblanco E, Perpiñán H, et al. Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes. Atherosclerosis. 2018;276:50–57.30032025
   PubMed Web of Science ®Google Scholar
• Choi IJ, Lim S, Choo EH, et al. Differential impact of chronic kidney disease on coronary calcification and atherosclerosis in asymptomatic individuals with or without diabetes: analysis from a coronary computed tomographic angiography registry. Cardiorenal Med. 2018;8(3):228–236.29961069
   PubMed Web of Science ®Google Scholar
• Arroyo D, Betriu A, Martinez-Alonso M, et al. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study. BMC Nephrol. 2014;18(15):168.
   Web of Science ®Google Scholar
• Pitha J, Teplan V, Kalousova M, et al. Gender-related determinants of advanced subclinical atherosclerosis in patients undergoing kidney transplantation. Kidney Blood Press Res. 2010;33(3):227–234.20588060
   PubMed Web of Science ®Google Scholar
• Gracia M, À B, Martínez-Alonso M, et al. Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD. Clin J Am Soc Nephrol. 2016;11(2):287–296.26668022
   PubMed Web of Science ®Google Scholar
• Kokubo Y. Carotid atherosclerosis in kidney disease. Contrib Nephrol. 2013;179:35–41.23652447
   PubMed Web of Science ®Google Scholar
• Buscemi S, Geraci G, Massenti FM, et al. Renal function and carotid atherosclerosis in adults with no known kidney disease. Nutr Metab Cardiovasc Dis. 2017;27(3):267–273.27979705
   PubMed Web of Science ®Google Scholar
• Wu Y, Hou J, Li J, et al. Correlation between carotid intima-media thickness and early-stage chronic kidney disease: results from asymptomatic polyvascular abnormalities in community study. J Stroke Cerebrovasc Dis. 2016;25(2):259–265.26500173
   PubMed Web of Science ®Google Scholar
• Shimizu M, Furusyo N, Mitsumoto F. T et al. Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS). Atherosclerosis. 2015;238(2):207–212.25528429
   PubMed Web of Science ®Google Scholar
• Muscogiuri G, Annweiler C, Duval G, et al. Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke. Int J Cardiol. 2017;230:577–584.28043680
   PubMed Web of Science ®Google Scholar
• Kim JK, Song YR, Kim MG, et al. Clinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients. BMC Cardiovasc Disord. 2013;13:96.24192205
   PubMed Web of Science ®Google Scholar
• Patel ML, Sachan R, Singh GP, et al. Assessment of subclinical atherosclerosis and endothelial dysfunction in chronic kidney disease by measurement of carotid intima media thickness and flow-mediated vasodilatation in North Indian population. J Family Med Prim Care. 2019;8:1447–1452.31143737
   PubMedGoogle Scholar
• Martín M, Valls J, Betriu A, et al. Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference. Atherosclerosis. 2015;241(1):264–270.25748053
   PubMed Web of Science ®Google Scholar
• Ohara T, Kokubo Y, Toyoda K, et al. Impact of chronic kidney disease on carotid atherosclerosis according to blood pressure category: the Suita study. Stroke. 2013;44(12):3537–3539.24085020
   PubMed Web of Science ®Google Scholar
• Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2018;25(11):1262–1274.30358722
   PubMed Web of Science ®Google Scholar
• Nofer JR. Estrogens and atherosclerosis: insights from animal models and cell systems. J Mol Endocrinol. 2012;48(2):R13–29.22355098
   PubMed Web of Science ®Google Scholar
• Palanca A, Castelblanco E, À B, et al. Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease. Cardiovasc Diabetol. 2019;18(1):93.31324183
   PubMed Web of Science ®Google Scholar
• Ahotupa M. Oxidized lipoprotein lipids and atherosclerosis. Free Radic Res. 2017;51(4):439–447.28412863
   PubMed Web of Science ®Google Scholar
• Pan J, Liu J, Wang H, et al. Association of carotid atherosclerosis with Lipid components in asymptomatic low-income Chinese: a population-based cross-sectional study. Front Neurol. 2020;11:276.32390928
   PubMed Web of Science ®Google Scholar